Ole Thastrup

Ole Thastrup serves as Founder; Chief Executive Officer at 2cureX - Individualizing Cancer Treatment. 2cureX - Individualizing Cancer Treatment operates in the hospital & health care sector with approximately 14.0 employees. 2cureX - Individualizing Cancer Treatment generates annual revenue of 1400000.0. To date, 2cureX - Individualizing Cancer Treatment has raised 935350.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 6,447 executives in the hospital & health care sector.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 WordPress.org Google Tag Manager Varnish Apache reCAPTCHA Mobile Friendly AI

cancer treatment personalized medicine colon cancer inditreat biotech in vitro diagnostic ovarian cancer vitro drug screening personalized medical treatment diagnostic instrumentation tumoroid technology 3d culture patientfocused drug discovery breast cancer functional precision medicine precision medicine ivd diagnostics 3d microtumors hospitals & health care drug sensitivity functional testing ivd test tumor response clinical trials 3d tumoroids pharmacogenomics oncology diagnostics personalized therapy medical technology biomedical research chemotherapy effectiveness patient-derived tumors tumor growth inhibition metastatic colorectal cancer mcrc drug resistance clinical evidence therapeutic decision-making real-world data tumor profiling chemotherapy regimens patient outcomes biomarker analysis genomic variability targeted therapy digital health laboratory testing healthcare innovation medical devices patient stratification tumor microenvironment research & development clinical validation healthcare providers treatment efficacy therapeutic optimization in vitro diagnostics oncological assays science-based medicine drug screening biomarkers treatment guidance therapeutic resistance trial design healthcare solutions hospital & health care health care health wellness & fitness information technology & services

DR

Donna Rey Executive Director & CEO at 1199SEIU National Benefit Fund

AS

Amin Shivji Chief Executive Officer at 123Dentist

JL

Jeff Leger Chief Executive Officer (incoming) at 123Dentist

CA

Chandan Advani Co - Chief Executive Officer at 123Dentist

ST

Stuart Tait Chief Executive Officer at 13SICK National Home Doctor

Outreach Guidance — hospital & health care Sector

Executives like Ole Thastrup in the hospital & health care sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at 2cureX - Individualizing Cancer Treatment.

How do I reach Ole Thastrup directly?

Ole Thastrup's verified email address is available to MessageCEO Pro subscribers. They currently serve as Founder; Chief Executive Officer at 2cureX - Individualizing Cancer Treatment. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Ole Thastrup work for?

Ole Thastrup is Founder; Chief Executive Officer at 2cureX - Individualizing Cancer Treatment, a company in the hospital & health care sector with 14.0 employees.

Can I pitch or sell to Ole Thastrup?

As Founder; Chief Executive Officer at 2cureX - Individualizing Cancer Treatment, Ole Thastrup is a key decision-maker in the hospital & health care sector. MessageCEO Pro gives you verified email to reach Ole Thastrup directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Ole Thastrup in?

Ole Thastrup works in the hospital & health care industry as Founder; Chief Executive Officer at 2cureX - Individualizing Cancer Treatment. MessageCEO provides verified contact information for executives across all major industries.

Is Ole Thastrup's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Ole Thastrup's profile is kept up-to-date with the latest available information.

Last updated: May 7, 2026